Concepedia

Sally Hopkins-Donaldson

SH

Statistics

Publications

11

Citations

709

H-Index

11

Active since

2000

Affiliations

University Hospital of Zurich(Current)

University Hospital of Lausanne

University of Lausanne

University of Bern

Sally Hopkins-Donaldson is an author at University Hospital of Zurich specializing in oncology, apoptosis, and apoptosis in cancer.

Publications per year

2000–2008

11

Publications

11

Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Sally Hopkins-Donaldson, Jean-Luc Bodmer, Katia Balmas Bourloud et al. · PubMed · 2000 · 247 citations

, , +17

Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma

de Aguirre, Patricia Boya, Daniel Bellet et al. · APOPTOSIS · 2004 · 78 citations

, , +17

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Larisa Belyanskaya, Thomas M. Marti, Sally Hopkins-Donaldson et al. · Molecular Cancer · 2007 · 67 citations · Full text

, , +17

Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis

Sally Hopkins-Donaldson, Jean-Luc Bodmer, Katia Balmas Bourloud et al. · Medical and Pediatric Oncology · 2000 · 53 citations

, , +17

TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8

Larisa Belyanskaya, Algirdas Ziogas, Sally Hopkins-Donaldson et al. · Lung Cancer · 2008 · 52 citations

, , +16

1–5 of 11